Share Name Share Symbol Market Type Share ISIN Share Description
Midatech Pharma Plc LSE:MTPH London Ordinary Share GB00BKT14T00 ORD 0.1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.50 1.45% 35.00 34.00 36.00 35.50 34.00 34.50 840,985 13:32:15
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 0.3 -10.9 -50.0 - 21

Midatech Pharma PLC Publication of Annual Report

30/06/2020 1:37pm

UK Regulatory (RNS & others)

Midatech Pharma (LSE:MTPH)
Historical Stock Chart

From Jun 2020 to Aug 2020

Click Here for more Midatech Pharma Charts.


RNS Number : 5637R

Midatech Pharma PLC

30 June 2020

30 June 2020

Midatech Pharma PLC

("Midatech" or the "Company")

Publication of Annual Report

Midatech Pharma PLC (AIM: MTPH.L; Nasdaq: MTP), a drug delivery technology company focused on improving the bio-delivery and bio-distribution of medicines announces that electronic copies of its Annual Report and Accounts for the year ended 31 December 2019 are now available from the Company's investor relations website at . Hard copies of the 2019 Annual Report and Accounts are expected to be posted to shareholders shortly.

For more information, please contact:

  Midatech Pharma PLC 
  Stephen Stamp, CEO, CFO 
  Tel: +44 (0)1235 888300 
  Panmure Gordon (UK) Limited (Nominated Adviser and Broker) 
  Freddy Crossley, Emma Earl (Corporate Finance) 
  James Stearns (Corporate Broking) 
  Turner Pope Investments (TPI) Limited (Joint Broker) 
  Andrew Thacker (Corporate Broking) 
  Tel: +44(0)20 3657 0050 
  IFC Advisory Limited (Financial PR and UK Investor Relations) 
  Tim Metcalfe / Graham Herring 
  Tel: +44 (0)20 3934 6630 
  Edison Group (US Investor Relations) 
   Joseph Green/ Laine Yonker 
   Tel: (646) 653-7030/ 7035 

About Midatech Pharma PLC

Midatech Pharma PLC (dual listed on LSE AIM: MTPH; and NASDAQ: MTP) is an R&D company focused on 'Making Medicines Better' by improving delivery of drugs in the body. The Company combines existing medications with its proprietary and innovative drug delivery technologies to provide compelling oncology and rare disease products that have the potential to powerfully impact the lives of patients undergoing treatment for life threatening diseases.

The Company has developed three in-house technology platforms, each with its own unique mechanism to improve delivery of medications to sites of disease. All of the Company's technologies have successfully entered human use in the clinic, providing important validation of the potential for each platform:

  --  Q-Sphera(TM) platform: a disruptive micro-technology used for sustained release to prolong 
       and control the release of therapeutics over an extended period of time (from weeks to months). 
  --  MidaSolve(TM) platform: an innovative nano-technology used to dissolve insoluble drugs so 
       that they can be administered in liquid form directly and locally into tumours. 
  --  MidaCore(TM) platform: a leading edge nano-technology used for targeting medications to sites 
       of disease. 

By improving biodelivery and biodistribution of approved existing molecules, Midatech's unique R&D has the potential to make medicines better, lower technical risks, accelerate regulatory approval and route to market, and provide newly patentable products. The platform nature of the technologies allows the potential to develop multiple drug assets rather than being reliant on a limited number of programmes.

Midatech's headquarters and R&D facility is in Cardiff, UK. For more information please visit

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact or visit



(END) Dow Jones Newswires

June 30, 2020 08:37 ET (12:37 GMT)

1 Year Midatech Pharma Chart

1 Year Midatech Pharma Chart

1 Month Midatech Pharma Chart

1 Month Midatech Pharma Chart
ADVFN Advertorial
Your Recent History
Midatech P..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20200811 02:08:58